Cambridge Nutritional Sciences PLC

As of March 31, 2026, Cambridge Nutritional Sciences PLC carries a market capitalization of 440.21M, placing it among publicly traded companies globally. Its enterprise value stands at 189.01M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Cambridge Nutritional Sciences PLC's next confirmed earnings release is scheduled for November 19, 2026.

As of March 31, 2026, Cambridge Nutritional Sciences PLC has 237.95M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Cambridge Nutritional Sciences PLC maintains a current ratio of 3.40, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, Cambridge Nutritional Sciences PLC's stock has declined approximately 40.74% over the past 52 weeks. The 50-day moving average sits at 1.66, while the 200-day moving average is 1.84.

As of March 31, 2026, Cambridge Nutritional Sciences PLC holds 263.70M in cash and equivalents against 12.50M in total debt, resulting in a net debt position of -263.70M. Total book value stands at 568.10M, with working capital of 398.40M providing operational flexibility.

Cambridge Nutritional Sciences PLC's most recent stock split took place on June 22, 2020 with a 80:81 split ratio.